Impact of TRIPS and RTAs on the Indian Pharmaceutical Product Exports

Loitongbam, Bishwanjit Singh (2016): Impact of TRIPS and RTAs on the Indian Pharmaceutical Product Exports.

Abstract

Until India fully implemented TRIPS in 2005, the Indian pharmaceutical industry had maintained a comparative advantage of cheap and skilled workers among developing economies. However, recent changes in regulatory environment have made the situation challenging for the industry. India seems to be losing its position in the global arena in both the production of bulk drugs and formulations. This paper investigates how TRIPS (implemented by partner countries) and Regional Trade Agreements (RTAs) influence Indian pharmaceutical product exports, using the Gravity Model. This analysis finds that TRIPS has negative effect on Indian pharmaceutical products exports. And RTAs increase pharmaceutical products exports.

• Item Type: MPRA Paper
• Language: English
• Keywords: TRIPS, RTA, Gravity Model, Indian Pharmaceutical Industry
• Subjects: F - International Economics > F1 - Trade > F13 - Trade Policy ; International Trade Organizations; F - International Economics > F1 - Trade > F14 - Empirical Studies of Trade; F - International Economics > F6 - Economic Impacts of Globalization; F - International Economics > F6 - Economic Impacts of Globalization > F68 - Policy

References

Anderson, J. E. (1979). “A Theoretical Foundation for the Gravity Equation”. The American Economic Review, Vol. 69, No.1, pp.106-116.

Anderson, J. E. (2011). "The Gravity Model". Annual Review of Economics, Vol. 3, No. 3, pp.133-160.

Anderson, J.E. and Wincoop, E. van. (2003). Gravity with Gravitas. The American Economic Review, Vol. 93, No. 1, pp. 170-192.

Bedi, N., Bedi, P.M.S. & Sooch, B.S. (2013). “Patenting and R&D in Indian Pharmaceutical Industry: Post-TRIPS Scenario”. Journal of Intellectual Property Rights, Vol. 18, No.18, pp.105-110.

Bouet, D. (2015). “A study of intellectual property protection policies and innovation in the Indian pharmaceutical industry and beyond”. Technovation, Vol. 38, pp. 31–41.

Chadha, A. (2009). “TRIPs and Patenting Activity: Evidence from the Indian Pharmaceutical Industry”. Economic Modelling, Vol. 26, No. 2, pp.499-505.

Chaudhuri, S. (2007). "Is Product Patent Protection Necessary in Developing Countries for Innovation? R&D by Indian Pharmaceutical Companies after TRIPs”. Indian Institute of Management, Calcutta, Working Papers Series No. 614/ Sep. 2007.

Chaudhuri, S. (2011). " Multinationals and Monopolies Pharmaceutical Industry in India after TRIPs”. Indian Institute of Management, Calcutta, Working Papers Series No. 685/ Nov. 2011.

Chaudhuri, S., Goldberg, P.K., & Jia, P. (2006). “Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India”. The American Economic Review, Vol. 96, No. 5, pp.1477-1514.

Disdier, Anne-Ce´lia and Head, K. (2008). “The Puzzling Persistence of the Distance Effect on Bilateral Trade”. The Review of Economics and Statistics, Vol. 90, No. 1, pp. 37-48.

Feenstra, R.C., Markusen, J.A. and Rose, A.K. (1998). “Understanding the Home Market Effect and the Gravity Equation: The Role of Differentiating Goods”. NBER Working Paper No. 6804., http://www.nber.org/papers/w6804.

Fink, C. (2000). “How Stronger Patent Protection in India Might Affect the Behavior or Transnational Pharmaceutical Industries”. http://www-wds.worldbank.org/external/default/WDSContentServer/IW3P/IB/2000/06/27/000094946_00060905463269/additional/11.

Grace, C. (2004). “The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Considerations for Access to Medicines”. http://www.who.int/hiv/amds/Grace2China.pdf .

Guennif, S. & Ramani Sh. V. (2012). “Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework”. Research Policy, Vol. 41, No. 2, pp. 430-441.

Hafner, T. and Popp, D. (2011). “China and India as Suppliers of Affordable Medicines to Developing Countries”. Working Paper 17249, http://www.nber.org/papers/w17249.

Hanson, G.H., Lind, N. and Muendler M. (2014). “The Dynamics of Comparative Advantage”. NBER Working Paper No. 21753. , http://www.nber.org/papers/w21753 .

Jha, R. (2007). “Options for Indian Pharmaceutical Industry in the Challenging Environment”. Economic and Political Weekly, Vol. 42, No. 39, pp. 3958-3967.

Kiran, R. and Mishra, S. (2009a). “Changing Pragmatics of the Indian Pharmaceutical Industry in the Pre and Post TRIPS Period”. International Journal of Business and Management, Vol. 4, 206-220.

Kyle, M. and McGahan A. (2012). “Investments in Pharmaceuticals Before and After TRIPS ”. The Review of Economics and Statistics, Vol. 94, 1157-1172.

Lawless, M. (2010). “Deconstructing Gravity: Trade Costs and Extensive and Intensive Margins” . Canadian Journal of Economics, Vol. 43, 1149-1172.

McCalman, P. (2001). “Reaping What You Sow: An Empirical Analysis of International Patent Harmonization”. Journal of International Economics, Vol. 55, No. 1, pp.161-186.

Melitz, J. (2007). “North, South and Distance in the Gravity Model”. Europena Economic Review, Vol. 51, No. 4, pp. 971-991.

Pöyhönen, P. (1963). “A Tentative Model for the Volume of Trade Between Countries”. Weltwirtschafliches Archiv, Bd. 90, pp. 93-99.

Rose, A. (2004). “Do We Really Know That the WTO Increases Trade?”. The American Economic Review, Vol. 94, No. 1, pp. 98-114.

Tinbergen, J. (1962). “Shaping the World Economy: Suggestions for an International Economic Policy.”. New York: Twentieth-Century Fund.

Watal, J. (2000). “Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India Under the WTO TRIPS Agreement”. The World Economy, Vol. 23, No. 5, pp.733-752.